Categories: News

cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2024 Results

Charlotte, North Carolina–(Newsfile Corp. – May 13, 2024) – cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation’s leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Wednesday, May 15, 2024, to discuss the company’s March 31, 2024 second quarter of fiscal 2024 financial results and business progress.

CONFERENCE CALL DETAILS

Wednesday May 15, 2024, 4:20 p.m. Eastern Time
USA/Canada: 844-763-8274
International: 647-484-8814
Teleconference Replay dial in:
USA/Canada: 855-669-9658
International: 412-317-0088
Replay Passcode: 0905
Webcast/Webcast Replay link – available through May 15, 2025:
https://www.gowebcasting.com/13342

 

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and recognized hemp-derived cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products as well as Full Spectrum and Delta 9 THC products. The cbdMD brand currently includes high-quality, premium CBD products including tinctures, gummies, topicals, capsules, sleep aids and more. The Company’s Paw CBD brand includes formulated pet products including tinctures, chews and topicals in varying strengths. cbdMD also operates ATRx Labs, a line of functional mushroom supplements. To learn more about cbdMD and the complete line of products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the thousands of retail outlets that carry cbdMD products.

1 THC-free is defined as below the level of detection using validated scientific analytical tools.

Contact Information:

cbdMD, Inc.

Ronan Kennedy, CEO

Phone: +1 (704) 445-3064 email: IR@cbdmd.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/208791

Staff

Recent Posts

Helix Launches Clinico-Genomic Datasets for Cardiovascular, Metabolic, Immunology and Inflammation Disorders

Rich longitudinal clinical and genomic data through a network of diverse U.S. health systems.SAN MATEO,…

38 mins ago

Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million

BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced…

40 mins ago

Klick Health Adds 18 Senior Leaders as 27-Year Double-Digit Growth Spurt Continues

Independent health agency continues to attract industry’s brightest minds; fortifies teams companywide as part of…

41 mins ago

Women Gone Wild: Intuition Edition Book Launch and Tour

New York, New York--(Newsfile Corp. - June 7, 2024) - The much-anticipated second installment of…

45 mins ago

Fiscal Update: Bemax Estimates an Over 70% Revenue Increase

Dallas, Georgia--(Newsfile Corp. - June 7, 2024) - Bemax Inc. (OTC Pink: BMXC), a private…

45 mins ago

1933 Industries Announces Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO THE UNITED STATES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER,…

45 mins ago